| BRONCHOPULMONALE INFECTIES - VOLWASSENEN |
| |
| Gerichte therapie |
| |
| Streptococcus pneumoniae-penicilline gevoelig (MIC peni ≤ 0,06 mg/L) |
| Therapie |
amoxicilline 2g, dan 1g, 4x/dag iv
|
| Streptococcus pneumoniae-penicilline intermediair (MIC peni > 0,06 mg/L en ≤ 2 mg/L) |
| Therapie |
amoxicilline 2g iv, dan 1g, 6x/dag iv
|
| Streptococcus pneumoniae-penicilline resistent (MIC peni >2 mg/L) |
| Therapie |
ceftriaxon 2g, 2x/dag iv
|
| Haemophilus influenzae (ß-lactamase negatief) |
| Therapie |
amoxicilline 1g, 6x/dag iv
|
| Haemophilus influenzae (ß-lactamase positief) |
| Therapie |
amoxicilline/clavulaanzuur 1g, 4x/dag iv |
| Staphylococcus aureus (methicilline-gevoelig, MSSA) |
| Therapie |
flucloxacilline 1g, 6x/dag iv
|
| Staphylococcus aureus (methicilline-resistent, MRSA) |
| Therapie |
vancomycine |
| Pseudomonas aeruginosa |
| Therapie |
ceftazidim 2g, 3x/dag iv |
| Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis |
| Therapie |
amoxicilline/clavulaanzuur 1g, 4x/dag iv |
| Enterobacter spp., Serratia spp., Citrobacter spp. |
| Therapie |
levofloxacine 500 mg, 2x/dag iv |
| Legionella pneumophila |
| Therapie |
levofloxacine 500 mg, 2x/dag po of iv |
| Mycoplasma pneumoniae |
| Therapie |
clarithromycine 500mg, 2x/dag iv |
| (labo_h2_tabel) |
| |
|